Eric Jacobson

JULY 8, 2024

Revolutionize health care, making individualized, targeted pharmaceuticals more affordable. Kahn explains that if not carefully designed and vigilantly regulated AI will deepen income inequality, depressing wages while imposing winner-take-all markets across much of the economy.

Tacit Knowledge 81

Tacit Knowledge Competitive Advantage Pharmaceuticals Magazine 81

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 58

Pharmaceuticals Transportation Retail Long-term 58

The Horizons Tracker

FEBRUARY 22, 2022

It’s a market that is already worth $3.1 billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. “ There are cases with upload speeds of over 1Gbps.

Stephenson 114

Stephenson Wireless Christensen Automotive 114

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

JUNE 22, 2018

When your operational and back office processes are aligned you work efficiently and productively. By adapting your marketing strategy, you will be able to target new audiences for your products and services. Let’s look at the niche markets that you can tap into boost your business’s growth and profitability: Seniors.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Strategy Driven

JANUARY 24, 2011

Execution Gap Maker #2: Nokia Nokia’s share of the worldwide market for mobile phones continued to slip in 2010. Why was this once-dominant player unable to execute and maintain its market position? This is a book for the times we live in—and one that for many companies could mean the difference between success and failure.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 14

Pharmaceuticals Banking Chemicals Entrepreneur 14

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 16

COO Sample Telecommunications Automotive 16

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Health Care 17

Health Care Retail Operations Insurance 17

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. That can be a powerful marketing technique if you have the market muscle to pull it off. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 16

Supply Chain Open-book Software Niche Marketing 16

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 18

Software Licensing Long-term Telecommunications 18

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 16

Apparel Pharmaceuticals Finance Licensing 16

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Since energy startups operate in an ecosystem dominated by incumbents, they can benefit dramatically from use of incumbent resources.

Energy 15

Energy Finance IPO Biotechnology 15

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 16

Rogers Morale Long-term Pharmaceuticals 16

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. But there’s little evidence that much of this works. Insight Center.

Leadership Pipeline 16

Leadership Pipeline Leadership After Action Review Pharmaceuticals 16

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park. and the U.K.

Globalization 14

Globalization Innovation Decentralization Chemicals 14

Harvard Business Review

MARCH 2, 2011

Some tentative conclusions: There is not much of a market for stand-alone strategy studies any more. McKinsey teams are beavering away in places like the United Arab Emirates and the 'Stans — Turkmenistan, say, or Tajikistan — but they're as likely to be doing operations projects as pure strategy work.

Consultative 16

Consultative Strategy McKinsey Porter 16

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 14

Competitive Advantage Business Model Technology Marketing 14

Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Marketing activities today generate unprecedented amounts of data.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. This means they're buying drugs that could be similar to others already on or coming soon to the market. billion tender offer directly to shareholders.

Innovation 15

Innovation Company Biotechnology CFO 15

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. Develop and fund a sales and marketing capability from the outset. Let’s look at each of these.

Innovation 13

Innovation Rogers NGO Participative 13

Harvard Business Review

SEPTEMBER 26, 2011

The stock market is short-term-oriented. The market favorably receives projects with long-term payoffs, particularly those in research and development. Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. I disagree.

CEO 17

CEO Short-term Long-term Pharmaceuticals 17

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JULY 12, 2011

Microsoft and Intel, as is well known, have long sought alternatives to their being fused at the hip — Microsoft seeking alternative chip platforms for its software, and Intel supporting additional operating systems. PDF) But that would leave you out of the game for many new technologies and markets, where alliances are essential.

Management 15

Management Airlines How To Pharmaceuticals 15

Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. ” The thinking on diversification later changed, turning into skepticism in the 1970s and outright criticism in the 1980s.

Influence 15

Influence Education Pharmaceuticals Finance 15

Harvard Business Review

JANUARY 8, 2013

arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). He emailed Christopher Tan, a marketer with an interest in mobile technologies and experience building applications, and within 36 hours, they had come up with a prototype. But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 12

Company Pharmaceuticals Health Care Participative 12

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. The bulk of HCIT investment supports startups that sell data — clinical or operational information that is otherwise difficult for clients to obtain or to organize. demographics.

Health Care 13

Health Care Levitt Pharmaceuticals Competitive Advantage 13

Harvard Business Review

AUGUST 3, 2016

On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.

Globalization 12

Globalization Supply Chain Pharmaceuticals McKinsey 12

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Products 10

Products Productivity Company Engineering 10